-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RggFoy38VvjeG1kwhMrQu3s/SqHw8tSYyxVmjXTqUozk6jKb+zTgZQSsuQfNji0r jRLVp1HCia87/exe4J+75Q== 0001058217-03-000152.txt : 20030715 0001058217-03-000152.hdr.sgml : 20030715 20030714180145 ACCESSION NUMBER: 0001058217-03-000152 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20030520 FILED AS OF DATE: 20030715 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AUTOIMMUNE INC CENTRAL INDEX KEY: 0000879106 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 133489062 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1199 MADIA STREET CITY: PASADENA STATE: CA ZIP: 91103 BUSINESS PHONE: 6267921235 MAIL ADDRESS: STREET 1: 128 SPRING STREET CITY: LEXINGTON STATE: MA ZIP: 02173 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FERGUSON ALLAN R CENTRAL INDEX KEY: 0001030573 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-20948 FILM NUMBER: 03786003 BUSINESS ADDRESS: STREET 1: C/O ATLAS VENTURE STREET 2: 222 BERKELEY STREET CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 6178599290 MAIL ADDRESS: STREET 1: C/O ATLAS VENTURE STREET 2: 222 BERKELEY STREET CITY: BOSTON STATE: MA ZIP: 02116 4 1 primary_doc.xml PRIMARY DOCUMENT 4 2003-05-20 0 0000879106 AUTOIMMUNE INC AIMM 0001030573 FERGUSON ALLAN R 1 0 0 0 Stock Option (right to buy) 1.2 2003-05-20 4 A 0 6000 1.2 A 2004-05-20 2013-05-20 common stock 6000 75500 D The reporting person no longer has a reportable beneficial interest in 2000 shares of the issuer's common stock owned by his two daughters and included in the reporting person's prior beneficial ownership reports. The option becomes exercisable in four equal annual installments beginning on the first anniversary of the grant date specified in Column 3. The option expires at the close of business on the first to occur of (i) one year following the date the grantee ceases to be a director of the issuer for any reason and (ii) May 20, 2013. The reporting person timely filed this Form 4 on May 22, 2003. It is being re-filed upon the request of the SEC because the May 22, 2003 filing was illegible. Allan R. Ferguson 2003-05-22 -----END PRIVACY-ENHANCED MESSAGE-----